This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph Alvarado and His Work on SARS-CoV-2 Protease Inhibitors.
Introduction
Joseph Alvarado is an inventor associated with Cleveland, Ohio, and The Cleveland Clinic Foundation. His patent work includes research into compounds designed to inhibit a key enzyme used by SARS-CoV-2.
Latest Patents
Alvarado is listed on 1 patent: “Protease Inhibitors and Methods of Use.” The patent describes compounds that inhibit the 3C-like protease of SARS-CoV-2, along with pharmaceutical compositions containing those compounds. It also outlines potential methods of use, including treating viral infections such as coronavirus infections.
Career Highlights
Alvarado’s listed patent connects his work at The Cleveland Clinic Foundation with research into potential antiviral treatments. The disclosed compounds and methods focus on targeting a viral protease, an approach intended to support the development of treatments for coronavirus infection.
Collaborations
Alvarado’s listed coworkers include Shaun R. Stauffer and Jonathan D. Macdonald. Their names appear alongside his in connection with the patent on protease inhibitors and methods of use.
Conclusion
Joseph Alvarado’s patent work reflects research at The Cleveland Clinic Foundation into compounds that may help address viral infections by inhibiting the SARS-CoV-2 3C-like protease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile